NEW YORK — People across the country who depend on the drug Ozempic for treating Type-2 diabetes and obesity are having a hard time finding it. Ozempic helps manage type 2 diabetes — but can also help people lose weight, contributing to the shortage and leaving diabetics scrambling for other options. “We’ve heard reports of
PLAINSBORO, N.J. — Novo Nordisk has released two new diabetes medications, Ozempic (semaglutide injection 0.5 mg and 1 mg) and Fiasp (insulin aspart injection 100 units/ml), to U.S. pharmacies. Both medications gained Food and Drug Administration approval in 2017 and mark the latest advancements to Novo Nordisk’s diabetes portfolio, the company said Monday. Ozempic is a
PLAINSBORO, N.J. — Novo Nordisk this week gained Food and Drug Administration approval for Ozempic (semaglutide injection), a medication for type 2 diabetes. Also this week, Novo Nordisk and pharmacy benefit manager Prime Therapeutics said they signed a value-based contract for Victoza (liraglutide injection), another type 2 diabetes medication. A glucagon-like peptide (GLP-1) receptor agonist,
